For example, whereas mutations in the classic TSG NF1 interact with CNA loss in most cancer types (62.5%), the driver mutations in BRAF only interact with CNA gain in one of the four cancer types in which it is significantly mutated (skin cutaneous melanoma; SKCM) (Fig. 2a, Supplementary Fig. 6). The gene discussed is BRAF; the disease is cancer.